BioSpace News Archive

Clinical Enterprise, Inc., a Eurofins Scientific company, announced it has been awarded a U.S. Government agreement to expand national COVID-19 testing.

The COVID-19 pandemic continues to create stress and anxiety for many Canadians, particularly those who do not have ready access to their regular support networks.

Innovation Collective and AARP Innovation Labs launch the Better Aging Through Technology Pitch Competition, for companies, early-stage startups, and ideas that improve our quality of life as we age.

Extendicare Inc. announced the results of matters voted on at its annual and special meeting of shareholders held on May 27, 2021, which included the election as directors of the Company of all of the nominees listed in its management information and proxy circular dated April 15, 2021.

Battelle has been selected to manage the logistics of administering COVID-19 tests for millions of Americans in 16 states through the U.S. Health and Human Services’ Midwest Expanded Testing Coordination Hub, the Department of Defense announced May 26.

Galapagos NV (Euronext & Nasdaq: GLPG) today announced that 15 abstracts,including scientific updates, and data providing further understanding on the profile of filgotinib as a treatment for people with Rheumatoid Arthritis (RA), will be presented at the European League Against Rheumatism (EULAR) virtual congress 2021, 2-5 June.

Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), today announced first quarter 2021 financial results.

Augmedix, Inc. (OTCQX: AUGX), a leading provider of virtual medical documentation and live clinical support, today announced the company will be participating in the upcoming LD Micro Invitational XI investor conference.

Viracta Therapeutics, Inc. (Viracta or the Company), a precision oncology company targeting virus-associated malignancies, today announced that Company management will present at the Jefferies Virtual Healthcare Conference taking place June 1-4, 2021

Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines, today announced that the Company will present at the Jefferies Virtual Healthcare Conference on Thursday, June 3, 2021 at 11:00am EDT.